Pieris Pharmaceuticals (NASDAQ:PIRS) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note released on Thursday. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of NASDAQ PIRS opened at $0.20 on Thursday. The firm has a market capitalization of $19.42 million, a price-to-earnings ratio […]
More Stories
Advantest Co. (OTCMKTS:ATEYY) Short Interest Down 69.6% in December
Advantest Co. (OTCMKTS:ATEYY – Get Free Report) was the recipient of a significant drop in short interest in December. As...
Arkema S.A. (OTCMKTS:ARKAY) Sees Large Decline in Short Interest
Arkema S.A. (OTCMKTS:ARKAY – Get Free Report) was the recipient of a significant decline in short interest during the month...
Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFY) Sees Significant Drop in Short Interest
Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFY – Get Free Report) was the target of a significant drop in short interest during the month...
Short Interest in BAB, Inc. (OTCMKTS:BABB) Declines By 64.3%
BAB, Inc. (OTCMKTS:BABB – Get Free Report) saw a significant decrease in short interest in the month of December. As...
Short Interest in Brenntag SE (OTCMKTS:BNTGY) Drops By 77.6%
Brenntag SE (OTCMKTS:BNTGY – Get Free Report) saw a significant drop in short interest during the month of December. As...
Priority Technology (NASDAQ:PRTH) Shares Gap Up – Here’s What Happened
Priority Technology Holdings, Inc. (NASDAQ:PRTH – Get Free Report) shares gapped up before the market opened on Thursday . The...